If pancreatic cancer is a cause that matters to you, your Donor-Advised Fund (DAF) can help you make an impact. With DAFPay, powered by Chariot, recommending a grant to the Pancreatic Cancer Action ...

As part of our commitment to accelerate pancreatic cancer research through the All Together We Can campaign, PanCAN announces ...

Kazuki Sugahara, MD, PhD Columbia University Research Project: Tumor-penetrating stromal modification of ß5 integrin-rich pancreatic cancer Award: 2026 [...] READ MORE ...

Christopher Kemp, PhD Fred Hutchinson Cancer Research Center Research Project: Patient-derived models for functional precision oncology Award: 2026 [...] READ MORE ...

In 2026, in partnership with our generous donors and supporters, 12 research grants have been awarded through two programs. Grantees were selected through a peer-review process. PanCAN has awarded ...

The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of pancreatic cancer cases — a sweeping advance for a disease that has few ...

The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement today following the full data from Revolution ...

I can’t think of a more exciting and hopeful time for pancreatic cancer than now. We are finally beginning to reap the benefits of decades of research into this challenging cancer. Because KRAS ...

Today, the President’s budget request (PBR) was released, and while the PBR is just that – a request – it signals the administration’s priorities for the coming fiscal year 2027, and once again, it ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...